Showing results 1 - 10 of 30 for the tag: depression.
Happiness really does rub off-a person’s happiness depends on the happiness of others with whom they are connected, finds research published on bmj.com today.
Happiness is not just an individual experience or choice, but is dependent on the happiness of others to whom individuals are connected directly and indirectly, and requires close proximity to spread, say [...]
A report by a non-profit US medical organization suggests that military personnel who suffer severe or moderate traumatic brain injury (TBI) are at greater risk of long term health problems including Alzheimer’s-like dementia, aggression, symptoms similar to Parkinson’s disease, depression, and memory loss.
Titled “Gulf War and Health: Volume 7: Long-Term Consequences of Traumatic Brain Injury”, [...]
A 20 year study by American scientists suggests that happiness may spread from person to person because they found that people surrounded by happy people in their friends and family network were more likely to remain happy in the future.
The study was published online in the British Medical Journal, BMJ on 4 December by authors [...]
PatientsLikeMe, the leading online community for patients with life-changing conditions, announces the release of its newest PatientsLikeMeListen(TM) report: “Did the July 2008 PML announcement affect the Tysabri brand?” Among its findings, the report reveals that patients retained an overall positive perception of the Tysabri brand despite the July 2008 announcement of two additional PML cases.
“In [...]
Schering-Plough Corporation (NYSE: SGP - News) today reported that a planned interim analysis of a Phase II study showed that boceprevir, its investigational oral hepatitis C protease inhibitor, in combination with peginterferon and ribavirin markedly increased sustained virologic response (SVR) rates with 28 weeks of therapy and nearly doubled SVR with 48 weeks of therapy [...]
Gilead Sciences, Inc. (Nasdaq:GILD - News) today announced the presentation of two-year (96-week) data from two Phase III pivotal clinical trials, Studies 102 and 103, evaluating the safety and efficacy of once-daily Viread® (tenofovir disoproxil fumarate) among adult patients with chronic hepatitis B virus (HBV) infection. These data will be presented during oral sessions at [...]
Patients with schizoaffective disorder receiving paliperidone extended release tablets (paliperidone ER) for six weeks showed a significant improvement in their symptoms, according to a new study presented today at the U.S. Psychiatric & Mental Health Congress in San Diego, Calif.(1) In addition, safety findings were similar to published studies of paliperidone ER in the treatment [...]
Patients with schizoaffective disorder receiving paliperidone extended release tablets (paliperidone ER) for six weeks showed a significant improvement in their symptoms, according to a new study presented today at the U.S. Psychiatric & Mental Health Congress in San Diego, Calif.(1) In addition, safety findings were similar to published studies of paliperidone ER in the treatment [...]
Schering-Plough Corporation (NYSE: SGP - News) today reported that a planned interim analysis of a Phase II study showed that boceprevir, its investigational oral hepatitis C protease inhibitor, in combination with peginterferon and ribavirin markedly increased sustained virologic response (SVR) rates with 28 weeks of therapy and nearly doubled SVR with 48 weeks of therapy [...]
Gilead Sciences, Inc. (Nasdaq:GILD - News) today announced the presentation of two-year (96-week) data from two Phase III pivotal clinical trials, Studies 102 and 103, evaluating the safety and efficacy of once-daily Viread® (tenofovir disoproxil fumarate) among adult patients with chronic hepatitis B virus (HBV) infection. These data will be presented during oral sessions at [...]
